Sernova receives initial funds for development of severe hemophilia A therapy Feb. 17, 2016 No Comments
FDA awards orphan drug designation to NVX-508 for VOC and ACS in sickle cell disease Feb. 15, 2016 No Comments
Achillion Pharmaceuticals begins clinical study of complement factor D inhibitor Feb. 15, 2016 No Comments
BioCryst reports phase II/III results for liquid capsule formulation of avoralstat Feb. 10, 2016 No Comments
Novel fibrinogen mutations are associated with congenital hypofibrinogenemia Feb. 10, 2016 No Comments
Clinical trial data support the use of albutrepenonacog alfa in hemophilia B Feb. 9, 2016 No Comments
EMA confirms positive risk-benefit ratio of Xarelto for prevention of stroke in patients with AF Feb. 8, 2016 No Comments